Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Interview: Takeda Pharmaceutical CMSO Andrew Plump Talks R&D Strategy

Filed Under: Interviews Tagged With: , , , ,

Takeda Pharmaceutical Co. Ltd. (TYO:4502) has been undertaking a major restructuring of its R&D operations since 2016. The Chemical Daily…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
Concerns Arise for Pharmaceutical Supply Chain Amid Crisis in Ukraine
Concerns Arise for Pharmaceutical Supply Chain Amid Crisis…
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…
Coronavirus Report – Part 24: Survey Reveals 12 Japanese Pharmaceutical Firms Working to Develop Cures
Coronavirus Report – Part 24: Survey Reveals 12 Japanese…
METI Plans Major Funding for Biopharma Sector to Bolster Economic Security
METI Plans Major Funding for Biopharma Sector to Bolster…
Japanese Pharmaceutical Companies Join Forces to Launch Integrated Compounds Library
Japanese Pharmaceutical Companies Join Forces to Launch…